SI0994704T1 - Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases - Google Patents

Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases

Info

Publication number
SI0994704T1
SI0994704T1 SI9830778T SI9830778T SI0994704T1 SI 0994704 T1 SI0994704 T1 SI 0994704T1 SI 9830778 T SI9830778 T SI 9830778T SI 9830778 T SI9830778 T SI 9830778T SI 0994704 T1 SI0994704 T1 SI 0994704T1
Authority
SI
Slovenia
Prior art keywords
gabapentin
inflammatory diseases
medicament
manufacture
treating inflammatory
Prior art date
Application number
SI9830778T
Other languages
English (en)
Slovenian (sl)
Inventor
Denis Schrier
Charles Price Taylor Jr.
Karin Nanette Westlund-High
Original Assignee
Board Of Regents,
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26728613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0994704(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Board Of Regents,, Warner-Lambert Company Llc filed Critical Board Of Regents,
Publication of SI0994704T1 publication Critical patent/SI0994704T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI9830778T 1997-06-25 1998-06-24 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases SI0994704T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5073697P 1997-06-25 1997-06-25
US8418398P 1998-05-04 1998-05-04
EP98934170A EP0994704B1 (en) 1997-06-25 1998-06-24 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
PCT/US1998/013107 WO1998058641A1 (en) 1997-06-25 1998-06-24 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases

Publications (1)

Publication Number Publication Date
SI0994704T1 true SI0994704T1 (en) 2005-10-31

Family

ID=26728613

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830778T SI0994704T1 (en) 1997-06-25 1998-06-24 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases

Country Status (20)

Country Link
EP (1) EP0994704B1 (da)
JP (2) JP3884486B2 (da)
KR (1) KR100554319B1 (da)
AT (1) ATE297722T1 (da)
AU (1) AU735675B2 (da)
CA (1) CA2294607C (da)
CO (1) CO4940456A1 (da)
DE (1) DE69830586T2 (da)
DK (1) DK0994704T3 (da)
ES (1) ES2244070T3 (da)
HR (1) HRP980342A2 (da)
HU (1) HU228454B1 (da)
IL (2) IL132709A0 (da)
IS (1) IS2279B (da)
NO (1) NO329321B1 (da)
NZ (1) NZ501626A (da)
PL (1) PL191370B1 (da)
PT (1) PT994704E (da)
SI (1) SI0994704T1 (da)
WO (1) WO1998058641A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0934061T6 (da) 1996-07-24 2015-01-26 Warner Lambert Co Isobutylgaba og dets derivater til behandling af smerte
TR200001170T2 (tr) 1997-10-27 2000-10-23 Warner-Lambert Company Farmasötik maddeler olarak faydalı siklo amino asitler ve bunların türevleri
AU2463099A (en) * 1998-01-23 1999-08-09 Warner-Lambert Company Gabapentin and its derivatives for the treatment of muscular and skeletal pain
EP0974351A3 (en) * 1998-04-24 2000-12-13 Jouveinal Medicament for preventing and treating gastrointestinal damage
ATE359068T1 (de) 1999-07-22 2007-05-15 Univ Rochester Methode zur behandlung der symptome hormoneller veränderungen, einschliesslich hitzewallungen
US6620829B2 (en) 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
EP2240158A2 (en) * 2007-12-28 2010-10-20 Intas Pharmaceuticals Limited Stabilized injectable formulation of pregabalin
HU230031B1 (hu) 2010-03-01 2015-05-28 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
US20130078290A1 (en) 2010-06-01 2013-03-28 Rubicon Research Private Limited Gastroretentive Dosage Forms Of GABA Analogs
TW201613625A (en) * 2014-08-29 2016-04-16 Wakamoto Pharma Co Ltd Lactic acid bacteria-containing composition
GB201617380D0 (en) 2016-10-13 2016-11-30 St George's Hospital Medical School Treatment for Osteoarthritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS6036413A (ja) * 1983-08-09 1985-02-25 Kaneshiro Nagai 炎症治癒促進剤
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
JPH0636413A (ja) * 1992-07-21 1994-02-10 Nakamichi Corp テ−プレコ−ダのテ−プガイド装置
DK0934061T6 (da) * 1996-07-24 2015-01-26 Warner Lambert Co Isobutylgaba og dets derivater til behandling af smerte
BR9712651A (pt) * 1996-10-23 1999-10-26 Warner Lambert Co ‡cidos gama-aminobutìricos substituìdos com agentes farmacêuticos.

Also Published As

Publication number Publication date
CO4940456A1 (es) 2000-07-24
JP2006298929A (ja) 2006-11-02
HUP0003730A3 (en) 2002-01-28
IL132709A (en) 2006-10-05
DK0994704T3 (da) 2005-10-03
AU8375898A (en) 1999-01-04
ATE297722T1 (de) 2005-07-15
PL191370B1 (pl) 2006-05-31
JP2002506449A (ja) 2002-02-26
ES2244070T3 (es) 2005-12-01
IL132709A0 (en) 2001-03-19
HUP0003730A1 (hu) 2001-04-28
JP3884486B2 (ja) 2007-02-21
DE69830586T2 (de) 2005-12-15
KR20010020509A (ko) 2001-03-15
HU228454B1 (en) 2013-03-28
AU735675B2 (en) 2001-07-12
IS5239A (is) 1999-11-05
KR100554319B1 (ko) 2006-02-22
HRP980342A2 (en) 1999-02-28
CA2294607C (en) 2007-09-25
WO1998058641A1 (en) 1998-12-30
NO996468L (no) 2000-02-21
CA2294607A1 (en) 1998-12-30
DE69830586D1 (de) 2005-07-21
PT994704E (pt) 2005-08-31
IS2279B (is) 2007-09-15
NZ501626A (en) 2002-03-28
NO329321B1 (no) 2010-09-27
PL337847A1 (en) 2000-09-11
EP0994704B1 (en) 2005-06-15
NO996468D0 (no) 1999-12-23
EP0994704A1 (en) 2000-04-26
JP4452255B2 (ja) 2010-04-21

Similar Documents

Publication Publication Date Title
PL338705A1 (en) Application of gaba analogues in preventing and treating gastrointestinal diseases
IL132709A0 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
PT880350E (pt) Tratamento de esclerose multipla
IL126999A0 (en) Isobutylgaba and its derivatives for the treatment of pain
DE69429365D1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
CA2144728A1 (en) Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium
IL71650A0 (en) Treatment of seizure disorders and pharmaceutical compositions useful therein
IL130500A (en) Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
IL126157A0 (en) Method for treating excessive aggression
BR9812265A (pt) Uso de análogos de gaba, tais como gabapentina, na fabricação de um medicamento para o tratamento de doenças inflamatórias.
UA10995C2 (uk) Препарат "hейтрам" для лікуваhhя hеоhатальhих діарей у телят
PL345953A1 (en) The treatment of renal colic with gaba analogs
HUP9902723A2 (hu) Olanzapin alkalmazása migrénes fájdalom kezelésére szolgáló gyógyszerkészítmény előállítására